Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BiovaxID in Follicular Lymphoma
NCT00091676Phase 3Unknown
- Sponsor
- Biovest
- Start
- Jan 2000
- Primary completion
- Dec 2012
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
01
Overview
A Phase 3 trial of Dasiprotimut-T in follicular lymphoma (FL), sponsored by Biovest. Status: unknown.
02
Drugs
Dasiprotimut-T
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00091676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00091676.